Using Selectivity of Fused-Core® Particles to Optimize Resolution for Improved LC and LCMS Method Development

Bonded Phase: AQ-C18, Biphenyl, C18, C30, C8, ES-CN, PFP, Phenyl-Hexyl, RP-Amide

Document Type: White Paper

Market Segment: Pharmaceuticals

Particle Size: 2.7 µm

Pore Size: 90 Å

Product Segment: SMALL MOLECULE

Separation Mode: Reversed Phase